Heartflow (HTFL) Free Cash Flow (2024 - 2025)
Heartflow's quarterly Free Cash Flow came in at -$12.5 million in Q4 2025, up 13.05% year-on-year from -$11.1 million in Q4 2024, and down 198.07% quarter-over-quarter from -$4.2 million in Q3 2025.
Heartflow has reported Free Cash Flow for 2 years, with the latest figure at -$12.5 million in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow rose 13.05% year-over-year to -$12.5 million; the trailing twelve-month figure through Dec 2025 stood at -$31.1 million (down 21.05% YoY), and the FY2025 full-year result was -$59.0 million, up 19.51% from the prior year.
- Free Cash Flow for Q4 2025 stood at -$12.5 million, down from -$4.2 million in the prior quarter.
- The five-year high for Free Cash Flow was -$4.2 million in Q3 2025, with the low at -$14.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 99.82 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 119.28 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 81.60 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 43.06 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 107.27 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 69.59 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 26.00 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -49.47 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 42.07 Mn |
| 10 | Heartflow | 1.15 Bn | 974.90 Mn | 39.06 Mn | -12.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12.50 Mn |
| Dec 31, 2025 | -12.50 Mn |
| Sep 30, 2025 | -4.19 Mn |
| Sep 30, 2025 | -4.19 Mn |
| Dec 31, 2024 | -14.37 Mn |
| Dec 31, 2024 | -14.37 Mn |
| Sep 30, 2024 | -11.29 Mn |
| Sep 30, 2024 | -11.29 Mn |